Streetbeat News

Regulatory

MRK

The European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion recommending the approval of Merck's Keytruda in combination with Padcev (Enfortumab Vedotin) for the first-line treatment of unresectable or metastatic conditions.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 10:54 am

AZN

The FDA's Oncologic Drugs Advisory Committee acknowledged that AstraZeneca's Imfinzi (Durvalumab) met the primary endpoint of event-free survival for resectable non-small cell lung cancer (NSCLC) in the AEGEAN Phase 3 trial. The trial showed a tolerable safety profile for patients treated with Imfinzi in combination with neoadjuvant chemotherapy before surgery and as adjuvant monotherapy after surgery.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 10:52 am

BA

TSLA

The return of astronauts aboard Boeing's Starliner spacecraft remains uncertain due to technical issues, with NASA considering using SpaceX's Dragon spacecraft as a backup. The Starliner has faced multiple delays since its inception, and its success is crucial for Boeing to join SpaceX in shuttling astronauts to and from the ISS.

Portfolio Pulse from Anan Ashraf

July 26, 2024 | 10:18 am

AAPL

SPY

Apple has announced that it will adopt the voluntary AI safeguards established by the Biden administration. This move aligns Apple with the government's efforts to ensure responsible AI development and usage.

Portfolio Pulse from charles@benzinga.com

July 26, 2024 | 9:34 am

WINT

Windtree Therapeutics filed Form RW to withdraw its registration statement on Form S-1. This action indicates a change in the company's plans regarding the issuance of new securities.

Portfolio Pulse from charles@benzinga.com

July 26, 2024 | 9:32 am

AMKR

Amkor Technology has signed a preliminary memorandum of terms with the US Department of Commerce to establish an advanced packaging and test facility in Arizona.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 9:08 am

ETHW

GBTC

An Ethereum banner was raised outside the NYSE, symbolizing the cryptocurrency's growing importance on Wall Street. The Bitwise Ethereum ETF (NYSE:ETHW) was prominently displayed, marking a significant moment in the crypto industry. The approval of spot Ethereum ETFs has led to high trading volumes and significant inflows.

Portfolio Pulse from Aniket Verma

July 26, 2024 | 6:50 am

ABBV

AbbVie has received EU approval for SKYRIZI to treat moderately to severely active ulcerative colitis in adults. This marks the fourth approved indication for SKYRIZI in the EU, supported by data from two pivotal Phase 3 trials.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 6:48 am

AAPL

SSNLF

Epic Games announced that Fortnite will be available on Apple's iPhones and iPads in the EU, but will be pulled from Samsung's Galaxy Store. This move is part of Epic's strategy to protest against app stores that they believe are unfair to developers. The company will also make its games available on third-party stores like AltStore.

Portfolio Pulse from Ananya Gairola

July 26, 2024 | 6:11 am

THCH

TH International, the exclusive operator of Tim Hortons China, faces a delisting threat from Nasdaq due to non-compliance with the minimum bid price requirement. The company has until January 15, 2025, to regain compliance or potentially face delisting.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 5:26 am